Japan: Asahi Kasei Medical adds a biopharmaceutical CDMO to its bioprocess business

Asahi Kasei Medical, through its US subsidiary, has acquired Bionova Scientific in the US. Founded in 2014, Bionova, based in Fremont, is a provider of contract process development services and GMP-compliant contract manufacturing services to biopharmaceutical companies, especially those developing next-generation antibody based drugs. Next generation antibody based drugs differ from conventional antibody based drugs…

You must be a HMI Subscriber to view this content.

Subscribe Now »